arginyl-glycyl-aspartic acid has been researched along with Cerebrovascular Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, K; Coller, BS; Weisman, HF | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
New antiplatelet agents: platelet GPIIb/IIIa antagonists.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Humans; Immunoglobulin Fab Fragments; Integrins; Life Tables; Myocardial Ischemia; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Snake Venoms; Thrombosis | 1995 |